Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Medicina (Kaunas) ; 57(9)2021 Aug 24.
Article in English | MEDLINE | ID: mdl-34577789

ABSTRACT

Objectives: This study aimed to evaluate the prognostic significance and relationship of miR-497 and metadherin to hepatocellular carcinoma (HCC) tumor characteristics and patients' survival. Methods: This study enrolled 120 (60 HCC patients and 60 healthy) subjects. Serum miR-497 and metadherin mRNA relative expression were analyzed by real-time quantitative reverse transcription polymerase chain reaction. The overall survival (OS) of HCC patients was assessed using the Kaplan-Meier curve and log-rank test. Results: Serum miR-497 showed statistically significant downregulation in HCC patients compared to controls (p < 0.001). Serum metadherin mRNA relative expression was significantly upregulated in HCC patients compared to controls (p < 0.001). Both serum miR-497 and metadherin mRNA expression were significantly associated with the number of tumor foci (p = 0.028 and 0.001, respectively), tumor size (p = 0.022 and <0.001, respectively), nodal metastasis (p = 0.003 and 0.003, respectively), distant metastasis (p = 0.003 and 0.003, respectively), vascular invasion (p = 0.040 and <0.001, respectively), and BCLC staging (p = 0.043 and 0.004, respectively). The overall survival was lower in patients with low miR-497 expression (p = 0.046) and in patients with high metadherin expression (p < 0.001). Conclusions: The expression levels of miR-497 showed downregulation in HCC patients, but metadherin expression showed upregulation. Both markers were inversely related and closely correlated with tumor characteristics and patients' survival.


Subject(s)
Carcinoma, Hepatocellular , Liver Neoplasms , MicroRNAs , Biomarkers, Tumor/genetics , Carcinoma, Hepatocellular/genetics , Humans , Kaplan-Meier Estimate , Liver Neoplasms/genetics , MicroRNAs/genetics
2.
Medicina (Kaunas) ; 57(9)2021 Sep 05.
Article in English | MEDLINE | ID: mdl-34577857

ABSTRACT

Breast cancer (BC) is one of the most prevalent malignancies among females worldwide. Globally, distant metastases were reported to be responsible for a large proportion of breast cancer-related deaths. The metastasis-associated colon cancer-1 (MACC1) gene was reported as a reliable biomarker for early detection of metastasis and prediction of prognosis of breast cancer. This study investigated the prognostic significance of MACC1 in breast cancer in relation to the clinicopathologic characteristics and patients' survival. Furthermore, the possible correlation between MACC1 expression and the different immune cells in the tumor microenvironment was explored. MACC1 mRNA was identified using quantitative reverse transcription polymerase chain reaction in 120 breast cancer specimens and adjacent non-cancerous tissues. MACC1 mRNA expression was significantly higher in the cancerous relative to the non-cancerous tissues (p < 0.001). High MACC1 expression was significantly associated with poor prognostic parameters, such as larger tumor size, grade III tumors, positive nodal metastasis, lymphovascular invasion, stage III tumors, and elevated Ki-67 expression. Higher MACC1 mRNA levels were positively correlated with CD163+ tumor-associated macrophages (r = 0.614, p < 0.001), and were negatively correlated with CD56+ natural killer cells (r = -0.398, p < 0.001) and CD8+ cytotoxic T lymphocytes (r = -0.323, p < 0.001). MACC1 expression was associated with poor patient overall survival (OS) and progression-free survival (PFS) (p < 0.001). Multivariate analysis suggested that MACC1 expression and the presence of lymphovascular invasion could be independent prognostic indicators for breast cancer (p = 0.015 and 0.042, respectively). In conclusion, MACC1 is highly expressed in cancerous tissues and is significantly related to poor prognostic factors, overall survival, and progression-free survival. MACC1 may influence infiltration of the immune cells in the tumor microenvironment, enhance immune escape of tumor cells, and may serve as a reliable independent prognostic factor for breast cancer.


Subject(s)
Breast Neoplasms , Colonic Neoplasms , Biomarkers, Tumor/genetics , Breast Neoplasms/genetics , Female , Humans , Prognosis , Trans-Activators , Transcription Factors/genetics , Tumor Microenvironment
3.
Microb Pathog ; 116: 301-312, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29407236

ABSTRACT

OBJECTIVES: Pseudomonas aeruginosa producing extended spectrum ß-lactamase (ESßL) enzyme had the ability for antimicrobial resistance mechanisms and its multidrug-resistant (MDR) phenotype, has been increasingly reported as a major clinical concern worldwide. The aim of this study was to (i) characterize ESßL-producing MDR P. aeruginosa isolated from burn wound infections phenotypically and molecularly, (ii) evaluate the antibacterial activity of some essential oils (EOs) against selected ESßL-producing drug resistant P. aeruginosa and (iii) characterize a promising EO. METHODS: Identification and antibiotic susceptibility tests were performed for all isolates. ESßL production was detected phenotypically by an initial screening test (IST) and a phenotypic confirmatory test (PCT). Additionally, ESßL-producing isolates were also characterized molecularly. The antibacterial activity was detected using a disc diffusion method. Mechanisms of antibacterial action, the fatty acid profile, and functional groups characterization of the promising EO were analyzed using scanning and transmission electron microscopy (SEM & TEM), gas chromatography-mass spectrometry (GC-MS), and Fourier transform infrared (FTIR) spectroscopy, respectively. RESULTS: A total of 50 non duplicated P. aeruginosa isolates from the wound samples of burn patients were identified. Of these, MDR and pan-drug resistance (PDR) showed a high prevalence in 38 (76%) isolates obtained from 10 clusters, while 21 (42%) were identified as ESßL-producing MDR or PDR P. aeruginosa isolates. Phenotypic detection of ESßL production showed that 20% were considered positive ESßL-producing P. aeruginosa using the IST, and were increased to 56% by the PCT. The most prevalent ESßL-encoding gene was blaOXA-2 (60.7%), followed by blaIMP-7 (53.6%) and blaOXA-50 (42.8%). Ginger oil is the most efficient antibacterial agent and its antibacterial action mechanism is attributed to the morphological changes in bacterial cells. The oil characterization revealed that 9,12-Octadecadienoic acid methyl ester is the major fatty acid (50.49%) identified. CONCLUSION: The high incidence of drug-resistance in ESßL-producing P. aeruginosa isolated from burn wounds is alarming. As proven in vitro, EOs may represent promising natural alternatives against ESßL-producing PDR or MDR P. aeruginosa isolates.


Subject(s)
Burns/complications , Drug Resistance, Bacterial , Oils, Volatile/pharmacology , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/drug effects , Wound Infection/microbiology , beta-Lactamases/genetics , Adolescent , Adult , Animals , Child , Female , Zingiber officinale/chemistry , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Oils, Volatile/therapeutic use , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa/enzymology , Pseudomonas aeruginosa/genetics , Pseudomonas aeruginosa/isolation & purification , Wound Infection/drug therapy , Young Adult , beta-Lactamases/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...